文献速递妇科生殖医学

异位妊娠治疗中的差异

Disparities in the management of ectopic pregnancy.
PubMed 文献 · Am J Obstet Gynecol · 2017-03-10

基于美国 Perspective 数据库 2006–2015 年 62,588 例输卵管异位妊娠患者,78.4% 接受手术、21.6% 接受甲氨蝶呤治疗。甲氨蝶呤使用率从 2006 年 14.5% 升至 2015 年 27.3%(P<.001),输卵管造口术从 13.0% 降至 6.0%(P<.001)。黑人和西班牙裔患者及医疗补助、无保险患者接受保守治疗的可能性更低。

要点

  • 甲氨蝶呤使用率从 2006 年 14.5% 升至 2015 年 27.3%(P<.001)。
  • 输卵管造口术占比从 2006 年 13.0% 降至 2015 年 6.0%(P<.001)。
  • 黑人和西班牙裔及医疗补助、无保险患者接受输卵管保留手术的可能性更低。

核心结论

  • 异位妊娠的治疗存在显著差异,包括种族和保险相关的差异。

研究设计与样本

  • 使用 Perspective 数据库识别 2006–2015 年美国各医院诊断为输卵管异位妊娠的 62,588 例女性,按接受甲氨蝶呤或手术(输卵管造口或输卵管切除)分类,建立多变量模型分析治疗预测因素。

主要发现

  • 62,588 例中 49,090 例(78.4%)接受手术,13,498 例(21.6%)接受甲氨蝶呤。
  • 甲氨蝶呤使用率从 2006 年 14.5% 升至 2015 年 27.3%(P<.001)。
  • 手术患者中输卵管造口术从 2006 年 13.0% 降至 2015 年 6.0%(P<.001)。
  • 近年治疗、教学医院和高容量中心与甲氨蝶呤使用增加相关(P<.05)。
  • 医疗补助患者(调整风险比 0.92;95%CI 0.87–0.98)和无保险女性(调整风险比 0.87;95%CI 0.82–0.93)接受甲氨蝶呤的可能性低于商业保险患者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ectopic pregnancy is common among young women. Treatment can consist of either surgery with salpingectomy or salpingostomy or medical management with methotrexate. In addition to acute complications, treatment of ectopic pregnancy can result in long-term sequelae that include decreased fertility. Little is known about the patterns of care and predictors of treatment in women with ectopic pregnancy. Similarly, data on outcomes for various treatments are limited. OBJECTIVE: We examined the patterns of care and outcomes for women with ectopic pregnancy. Specifically, we examined predictors of medical (vs surgical) management of ectopic pregnancy and tubal conservation (salpingostomy vs salpingectomy) among women who underwent surgery. STUDY DESIGN: The Perspective database was used to identify women with a diagnosis of tubal ectopic pregnancy treated from 2006-2015. Perspective is an all-payer database that collects data on patients at hospitals from throughout the United States. Women were classified as having undergone medical treatment, if they received methotrexate, and surgical treatment, if treatment consisted of salpingostomy or salpingectomy. Multivariable models were developed to examine predictors of medical treatment and of tubal conserving salpingostomy among women who were treated surgically. RESULTS: Among the 62,588 women, 49,090 women (78.4%) were treated surgically, and 13,498 women (21.6%) received methotrexate. Use of methotrexate increased from 14.5% in 2006 to 27.3% by 2015 (P<.001). Among women who underwent surgery, salpingostomy decreased over time from 13.0% in 2006 to 6.0% in 2015 (P<.001). Treatment in more recent years, at a teaching hospital and at higher volume centers, were associated with the increased use of methotrexate (P<.05 for all). In contrast, Medicaid recipients (adjusted risk ratio, 0.92; 95% confidence interval, 0.87-0.98) and uninsured women (adjusted risk ratio, 0.87; 95% confidence interval, 0.82-0.93) were less likely to receive methotrexate than commercially insured patients. Among those who underwent surgery, black (adjusted risk ratio, 0.76; 95% confidence interval, 0.69-0.85) and Hispanic (adjusted risk ratio, 0.80; 95% confidence interval, 0.66-0.96) patients were less likely to undergo tubal conserving surgery than white women and Medicaid recipients (adjusted risk ratio, 0.69; 95% confidence interval, 0.64-0.75); uninsured women (adjusted risk ratio, 0.60; 95% confidence interval, 0.55-0.66) less frequently underwent salpingostomy than commercially insured patients. CONCLUSION: There is substantial variation in the management of ectopic pregnancy. There are significant race- and insurance-related disparities associated with treatment.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hsu JY, Chen L, Gumer AR, et al. Disparities in the management of ectopic pregnancy. Am J Obstet Gynecol. 2017. PMID: 28288792. doi:10.1016/j.ajog.2017.03.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。